why choose us

Clinical Trials Search

Showing 11,010 of 132,366 result(s)
DP303c in Patients With HER2-positive Advanced Breast Cancer

Status: NOT_YET_RECRUITING

Condition: HER2-positive Advanced Breast Cancer

Interventions: DP303c injection, 3.0 mg;kg, Q3W.

Date: 2023-06-04

Efficacy of Low Level LASER Therapy in Treating Temporomandibular Muscle Disorders

Status: COMPLETED

Condition: Temporomandibular Joint Dysfunction Syndrome

Interventions: using semiconductor InGaAsp diode LASER type 940 nm with continuous mode of operation, with time of application 180 sec per session for 12 sessions.

Date: 2023-06-04

Cadonilimab (AK104) With or Without CT as 2rd Line Treatment for ES-SCLC

Status: Completed

Condition: Immunotherapy

Interventions: Cadonilimab (10mg;kg, administered on the first day of each cycle, Q3W, until there is no clinical benefit)+platinum-based chemotherapy or Cadoni

Date: 2023-06-04

Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer

Status: NOT_YET_RECRUITING

Condition: Head and Neck Squamous Cell Carcinoma

Interventions: Given by IV

Date: 2023-06-04

Strengthen Family Members' Understanding of Advance Care Planning With a Nurse-led, Motivational Interview

Status: COMPLETED

Condition: Family Members

Interventions: Family member participants will receive three counselling sessions: (1) preparatory session, (2) motivation session, and (3) planning session.
Th

Date: 2023-06-04

Effect of Epidural Hydromorphone Combined With Ropivacaine in Labor Analgesia

Status: COMPLETED

Condition: Analgesia

Interventions: For those in H1 group: they will be administered with15 ug;ml hydromorphone, For those in H2 group: they will be administered with17.5 ug;ml

Date: 2023-06-04

The Correlation of Reduction of Levodopa and Non-motor Symptoms of Parkinson's Disease After Deep Brain Stimulation

Status: COMPLETED

Condition: Parkinson Disease

Interventions: Some patients did not reduced the dose of levodopa after STN-DBS comparing to some without reducing the dose.

Date: 2023-06-04

Efficacy of Lenalidomide Maintenance in Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma: a Phase II, Open-label, Single-arm Study

Status: NOT_YET_RECRUITING

Condition: Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma

Interventions: 1.8 Gy of 4-6 MV X-ray to a total dose of 23.4 Gy (13 fractions) will be delivered.

Date: 2023-06-04

A Study of [14C]-LY3537982 in Healthy Participants

Status: NOT_YET_RECRUITING

Condition: Healthy

Interventions: Administered orally.

Date: 2023-06-04

Homologous Recombination Repair Pathway Gene Mutation Spectrum in Chinese Breast Cancer Patients

Status: NOT_YET_RECRUITING

Condition: Breast Cancer

Interventions:

Date: 2023-06-04